GSK plc - SPONSORED ADR (GSK)

CUSIP: 37733W204

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / SPONSORED ADR
Total 13F shares
269,710,676
Share change
-5,902,155
Total reported value
$9,600,329,935
Put/Call ratio
51%
Price per share
$35.58
Number of holders
792
Value change
-$208,079,525
Number of buys
413
Number of sells
280

Quarterly Holders Quick Answers

What is CUSIP 37733W204?
CUSIP 37733W204 identifies GSK - GSK plc - SPONSORED ADR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of GSK plc - SPONSORED ADR (GSK) as of Q1 2023

As of 31 Mar 2023, GSK plc - SPONSORED ADR (GSK) was held by 792 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 269,710,676 shares. The largest 10 holders included Dodge & Cox, FMR LLC, JTC Employer Solutions Trustee Ltd, Fisher Asset Management, LLC, PRICE T ROWE ASSOCIATES INC /MD/, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, PRIMECAP MANAGEMENT CO/CA/, GOLDMAN SACHS GROUP INC, STATE STREET CORP, and MORGAN STANLEY. This page lists 793 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.